ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,438.65
0.00%
Dow Jones
39,869.38
-0.10%
Gold vs US Dollar
2,385.235
0.29%
Brent Oil
83.61
0.49%
Bitcoin
66,116.12
1.34%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Syntheticmr Ab (publ) (0G79)

  7. Syntheticmr Ab (publ) (0G79) News

Syntheticmr Ab (publ) (0G79)

Syntheticmr Ab (publ)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0G79
DateTimeSourceHeadlineSymbolCompany
17/04/202410:00PR Newswire (US)SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed FacilitiesLSE:0G79Syntheticmr Ab (publ)
27/03/202410:37PR Newswire (US)SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
01/03/202408:37UK RegulatoryPhilips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patientsLSE:0G79Syntheticmr Ab (publ)
18/12/202309:19PR Newswire (US)SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-MarkingLSE:0G79Syntheticmr Ab (publ)
30/11/202309:30PR Newswire (US)SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
30/11/202309:20PR Newswire (US)SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
08/02/202209:00PR Newswire (US)SyntheticMR Partners with Hyland to Utilize PACSgear Modlink SoftwareLSE:0G79Syntheticmr Ab (publ)
27/01/202212:43PR Newswire (US)SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) studyLSE:0G79Syntheticmr Ab (publ)
17/08/202115:16PR Newswire (US)SyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens HealthineersLSE:0G79Syntheticmr Ab (publ)
09/06/202113:40PR Newswire (US)SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical SystemsLSE:0G79Syntheticmr Ab (publ)
09/06/202113:27PR Newswire (US)SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical SystemsLSE:0G79Syntheticmr Ab (publ)
24/03/202109:00PR Newswire (US)SyntheticMR AB receives first order from United ImagingLSE:0G79Syntheticmr Ab (publ)
09/02/202107:51PR Newswire (US)SyntheticMR AB partners with United ImagingLSE:0G79Syntheticmr Ab (publ)
12/11/202015:35PR Newswire (US)Nomination Committee appointed for the 2021 Annual General Meeting in SyntheticMRLSE:0G79Syntheticmr Ab (publ)
09/11/202010:22PR Newswire (US)Dr. Alex Rovira from Hospital Vall d'Hebron joins SyntheticMR's Medical Advisory BoardLSE:0G79Syntheticmr Ab (publ)
19/10/202013:45PR Newswire (US)Dr. Jan Fritz of NYU Langone Health joins SyntheticMR's Medical Advisory BoardLSE:0G79Syntheticmr Ab (publ)
01/10/202007:28PR Newswire (US)SyntheticMR signs additional collaboration agreement with GE Healthcare MRLSE:0G79Syntheticmr Ab (publ)
01/10/202007:26PR Newswire (US)SyntheticMR signs additional collaboration agreement with GE Healthcare MRLSE:0G79Syntheticmr Ab (publ)
03/09/202010:30PR Newswire (US)SyntheticMR's software solution SyMRI receives regulatory approval in JapanLSE:0G79Syntheticmr Ab (publ)
03/09/202009:58PR Newswire (US)SyntheticMR's software solution SyMRI receives regulatory approval in JapanLSE:0G79Syntheticmr Ab (publ)
11/08/202013:07PR Newswire (US)SyntheticMR's product SyMRI now compatible with additional scanners from Siemens Healthineers on the US marketLSE:0G79Syntheticmr Ab (publ)
18/05/202008:06PR Newswire (US)Philips Healthcare US to Include SyntheticMR's Solution in Product CatalogueLSE:0G79Syntheticmr Ab (publ)
27/03/202008:08PR Newswire (US)World-leading Hospital Mayo Clinic Orders SyntheticMR's Solution For Clinical RoutineLSE:0G79Syntheticmr Ab (publ)
08/01/202014:04PR Newswire (US)SyntheticMRs Software SyMRI now in Clinical Routine for Pediatric Whole-brain Myelin Volume QuantificationLSE:0G79Syntheticmr Ab (publ)
08/08/201912:42PR Newswire (US)The SyMRI® NEURO Software From SyntheticMR AB is Now Available on syngo.via Open Apps from Siemens Healthineers in the USALSE:0G79Syntheticmr Ab (publ)
27/11/201807:49PR Newswire (US)SyMRI Software and Philips Ingenia Elition 3.0T MR are now Jointly Marketed in the USALSE:0G79Syntheticmr Ab (publ)
29/01/201807:18PR Newswire (US)SyntheticMR AB - Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI now ...LSE:0G79Syntheticmr Ab (publ)
29/01/201807:13PR Newswire (US)SyntheticMR AB - Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI now ...LSE:0G79Syntheticmr Ab (publ)
 Showing the most relevant articles for your search:LSE:0G79

Your Recent History

LSE
RMMC
River And Mercantile Uk ...
LSE
ELM
Elementis
LSE
PIZ
NASDAQI
COMP
NASDAQ Composite
LSE
PRES
Pressure Technologies
LSE
JARB
Jardine Matheson Holding...
LSE
GRP
Greencoat Renewables
LSE
CLL
Cello Health
LSE
0QCT
Roblon A/s
LSE
NASA
Nasstar
LSE
SBTX
Skinbiotherapeutics
LSE
TRT
Transense Technologies
LSE
POLY
Polymetal
BFNX
XRPUSD
Ripple
LSE
FOG
Falcon Oil & Gas
LSE
0RL0
Skeljungur
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved